The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Target-based therapeutic matching of phase I trials in patients with advanced breast cancer (BC pts) in the Royal Marsden Hospital Drug Development Unit (RMH DDU).
 
Brent O'Carrigan
No Relationships to Disclose
 
Awais Jalil
No Relationships to Disclose
 
Dionysios Papadatos-Pastos
No Relationships to Disclose
 
Samuel John Harris
No Relationships to Disclose
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Udai Banerji
No Relationships to Disclose
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Timothy Anthony Yap
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca; Clearbridge Biomedics; Vertex
Travel, Accommodations, Expenses - Janssen-Cilag; MSD Oncology; Vertex